Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 81, 2021 - Issue 5
Submit an article Journal homepage
163
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

A technical and clinical evaluation of the new ThermoFisher BRAHMS unconjugated estriol and inhibin-A assays and their use in second trimester Down syndrome screening

Daljit Singh SahotaDepartment of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, ChinaCorrespondence[email protected]
,
Fanny Ho Kau TsangDepartment of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
,
Jia Shi GuDepartment of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
,
Wai Kei Vicky FungDepartment of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
,
Kit Yee MokDepartment of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
&
Chui Lin WongDepartment of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
Pages 371-378 | Received 02 Dec 2020, Accepted 08 May 2021, Published online: 01 Jun 2021

References

  • Van Lith JM, Pratt JJ, Beekhuis JR, et al. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down’s syndrome. Prenat Diagn. 1992;12(10):801–806.
  • Spencer K, Wood PJ, Anthony FW. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down’s syndrome. Ann Clin Biochem. 1993;30(2):219–220.
  • Aitken DA, Wallace EM, Crossley JA, et al. Dimeric inhibin A as a marker for Down’s syndrome in early pregnancy. N Engl J Med. 1996;334(19):1231–1236.
  • Haddow JE, Palomaki GE, Knight GJ, et al. Second trimester screening for Down’s syndrome using maternal serum dimeric inhibin A. J Med Screen. 1998;5(3):115–119.
  • Cuckle HS, Holding S, Jones R, et al. Maternal serum dimeric inhibin A in second-trimester Down’s syndrome pregnancies. Prenat Diagn. 1995;15(4):385–386.
  • Knight GJ, Palomaki GE, Neveux LM, et al. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down’s syndrome screening. J Med Screen. 2001;8(1):2–7.
  • Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess. 2003;7(11):1–77.
  • Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med. 2005;353(19):2001–2011.
  • Chitty LS, Wright D, Hill M, et al. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units. BMJ. 2016;354:i3426.
  • National Institute for Biological Standards and Controls [Internet]. NIBSC code 91/624 - Inhibin A, human recombinant WHO International Standard. Herts (UK): NIBSC; Available from: https://www.nibsc.org/products/brm_product_catalogue/detail_page.aspx?catid=91/624
  • National Institute for Biological Standards and Controls [Internet]. NIBSC code 99/650 - chorionic gonadotropin, beta subunit, human WHO International Standard. Herts (UK): NIBSC; Available from: https://www.nibsc.org/products/brm_product_catalogue/detail_page.aspx?catid=99/650
  • National Institute for Biological Standards and Controls [Internet]. NIBSC code AFP. Alpha-foetoprotein. WHO International Standard. Herts (UK): NIBSC; Available from: https://www.nibsc.org/products/brm_product_catalogue/detail_page.aspx?catid=AFP
  • Cuckle H, Benn P, Wright D. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol. 2005;29(4):252–257.
  • Massé J, Forest JC, Moutquin JM, et al. Effect of repeated freeze-thaw cycles on maternal serum biological markers for the detection of fetal trisomies. Clin Biochem. 1997;30(7):527–530.
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327(8476):307–310.
  • Passing H, Bablok W, Bender R, et al. A general regression procedure for method transformation. J Clin Chem Clin Biochem. 1988;26:783–790.
  • Clinical and Laboratory Standards Institute. Measurement procedure comparison and bias estimation using patient samples; approved guideline. Third Edition. CLSI document EP09-A3. Wayne (PA): CLSI; 2018.
  • Cuckle HS, Wald NJ, Thompson SG. Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein. BJOG. 1987;94(5):387–402.
  • Reynolds TM, Penney MD. The mathematical basis of multivariate risk screening: with special reference to screening for Down’s syndrome associated pregnancy. Ann Clin Biochem. 1990;27(5):452–458.
  • Christiansen M, Larsen SO. Precision of risk in multidimensional likelihood ratio based screening with first trimester screening for Down’s syndrome as a special case. J Med Screen. 2001;8(2):61–64.
  • Sahota DS, Leung WC, Chan WP, et al. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme. Hong Kong Med J. 2013;19:101–108.
  • Cuckle H, Aitken D, Goodburn S, et al. Age-standardisation when target setting and auditing performance of Down syndrome screening programmes. Prenat Diagn. 2004;24(11):851–856.
  • Bestwick J, Huttly W, Wald NJ. Detection of trisomy 18 and trisomy 13 using first and second trimester Downs’ syndrome screening markers. J Med Screen. 2013;20(2):57–65.
  • Wilson G, Liitti P, Pölönen T, et al. A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screening. Clin Chem Lab Med. 2016;54(9):1473–1479.
  • Wallac Oy. AutoDELFIA® unconjugated estriol (uE3) time-resolved fluoroimmunoassay B083-301. Available from: https://www.perkinelmer.com/searchresult?searchType=othercontent&isResource=true&searchName=B083-301
  • BRAHMS GmbH. BRAHMS uE3 Kryptor. Available from: https://www.brahms.de/products/prenatal-screening/products-assays/ue3.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.